220 related articles for article (PubMed ID: 34198267)
1. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization,
Rizwanullah M; Perwez A; Mir SR; Alam Rizvi MM; Amin S
Nanotechnology; 2021 Jul; 32(41):. PubMed ID: 34198267
[TBL] [Abstract][Full Text] [Related]
2. Polymer-lipid hybrid nanoparticles of exemestane for improved oral bioavailability and anti-tumor efficacy: An extensive preclinical investigation.
Rizwanullah M; Perwez A; Alam M; Ahmad S; Mir SR; Rizvi MMA; Amin S
Int J Pharm; 2023 Jul; 642():123136. PubMed ID: 37311498
[TBL] [Abstract][Full Text] [Related]
3. Exemestane encapsulated vitamin E-TPGS-polymeric nanoparticles: preparation, optimization, characterization, and in vitro cytotoxicity assessment.
Mishra B; Padaliya R; Patel RR
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):522-534. PubMed ID: 27017970
[TBL] [Abstract][Full Text] [Related]
4. Formulation and Evaluation of Apigenin-Loaded Hybrid Nanoparticles.
Kazmi I; Al-Abbasi FA; Imam SS; Afzal M; Nadeem MS; Altayb HN; Alshehri S
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456617
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol-Loaded Polymeric Nanoparticles: The Effects of D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) on Physicochemical and Biological Properties against Breast Cancer In Vitro and In Vivo.
Cavalcante de Freitas PG; Rodrigues Arruda B; Araújo Mendes MG; Barroso de Freitas JV; da Silva ME; Sampaio TL; Petrilli R; Eloy JO
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345140
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization.
Maurya L; Singh S; Rajamanickam VM; Narayan G
Curr Drug Deliv; 2018; 15(8):1135-1145. PubMed ID: 29629662
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
[TBL] [Abstract][Full Text] [Related]
9. Design and Development of D‒α‒Tocopheryl Polyethylene Glycol Succinate‒
Yusuf O; Ali R; Alomrani AH; Alshamsan A; Alshememry AK; Almalik AM; Lavasanifar A; Binkhathlan Z
Molecules; 2021 May; 26(9):. PubMed ID: 34064416
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
[TBL] [Abstract][Full Text] [Related]
11. Application of quality-by-design approach to optimize diallyl disulfide-loaded solid lipid nanoparticles.
Talluri SV; Kuppusamy G; Karri VV; Yamjala K; Wadhwani A; Madhunapantula SV; Pindiprolu SS
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):474-488. PubMed ID: 27112220
[TBL] [Abstract][Full Text] [Related]
12. Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy.
Khan S; Aamir MN; Madni A; Jan N; Khan A; Jabar A; Shah H; Rahim MA; Ali A
Life Sci; 2021 Nov; 284():119909. PubMed ID: 34450169
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
Singh A; Neupane YR; Mangla B; Kohli K
J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
[TBL] [Abstract][Full Text] [Related]
14. Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy.
Huang L; Chen H; Zheng Y; Song X; Liu R; Liu K; Zeng X; Mei L
Integr Biol (Camb); 2011 Oct; 3(10):993-1002. PubMed ID: 21938302
[TBL] [Abstract][Full Text] [Related]
15. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
[TBL] [Abstract][Full Text] [Related]
16. Emodin-Loaded PLGA-TPGS Nanoparticles Combined with Heparin Sodium-Loaded PLGA-TPGS Nanoparticles to Enhance Chemotherapeutic Efficacy Against Liver Cancer.
Liu H; Xu H; Zhang C; Gao M; Gao X; Ma C; Lv L; Gao D; Deng S; Wang C; Tian Y
Pharm Res; 2016 Nov; 33(11):2828-43. PubMed ID: 27511028
[TBL] [Abstract][Full Text] [Related]
17. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
[TBL] [Abstract][Full Text] [Related]
19. Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells.
Suksiriworapong J; Phoca K; Ngamsom S; Sripha K; Moongkarndi P; Junyaprasert VB
Eur J Pharm Biopharm; 2016 Apr; 101():15-24. PubMed ID: 26802701
[TBL] [Abstract][Full Text] [Related]
20. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
